Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 1471 AL 1485

Mortality rates for Parkinson's disease are increasing in Spain. An age-period-cohort and joinpoint analysis of mortality rates from 1981 to 2020

García-Muñoz C, Hernández-Rodríguez JC, Pereyra-Rodriguez JJ.

Neurologia (Engl Ed). 2025 Mar;40(2):161-170. doi: 10.1016/j.nrleng.2023.06.003. Epub 2023 Jun 29.

Dopamine agonist therapy in Parkinson's disease: Spanish expert consensus on its use in different clinical situations

Santos García D, Pagonabarraga Mora J, Escamilla Sevilla F, García Ruiz PJ, Infante Ceberio J, Kulisevsky Bojarski J, Linazasoro Cristóbal G, Luquín Piudo MR, Martínez Castrillo JC, Jesús Maestre S, Vela Desojo L, Campos Lucas FJ, Caballero Martínez F, Mir P; Panel of Experts Phase 1.

Neurologia (Engl Ed). 2025 Mar;40(2):171-181. doi: 10.1016/j.nrleng.2023.04.008. Epub 2023 Jul 5.

Nanotheranostics: The Fabrication of Theranostics with Nanoparticles and their Application to Treat the Neurological Disorders

Singh A, Patel A, Chaudhary H, Yadav K, Minocha N.

Recent Pat Nanotechnol. 2025;19(1):17-34. doi: 10.2174/1872210517666230718115651.

Nigral volume loss in prodromal, early, and moderate Parkinson's disease

Langley J, Hwang KS, Huddleston DE, Hu XP.

medRxiv [Preprint]. 2025 Mar 21:2023.08.19.23294281. doi: 10.1101/2023.08.19.23294281.

Clinical and genetic insights of Parkinson's Disease in a Mexican cohort: highlighting Latino's diversity

Lázaro-Figueroa A, Reyes-Pérez P, Morelos-Figaredo E, Guerra-Galicia CM, Estrada-Bellmann I, Salinas-Barboza K, Matuk-Pérez Y, Gandarilla-Martínez NA, Oropeza D, Caballero-Sánchez U, Montés-Alcántara P, López-Pintor A, Angulo-Arrieta AP, Flores-Ocampo V, Espinosa-Méndez IM, Zayas-Del Moral A, Gaspar-Martínez E, Vazquez-Guevara D, Rodríguez-Violante M, Waldo E, Leal TP, Inca-Martinez M, Mata IF, Alcauter S, Rentería ME, Medina-Rivera A, Ruiz-Contreras AE.

medRxiv [Preprint]. 2025 May 3:2023.08.28.23294700. doi: 10.1101/2023.08.28.23294700.

Sexually dimorphic mechanisms of VGLUT-mediated protection from dopaminergic neurodegeneration

Buck SA, Rubin SA, Kunkhyen T, Treiber CD, Xue X, Fenno LE, Mabry SJ, Sundar VR, Yang Z, Shah D, Ketchesin KD, Becker-Krail DD, Vasylieva I, Smith MC, Weisel FJ, Wang W, Erickson-Oberg MQ, O'Leary EI, Aravind E, Ramakrishnan C, Kim YS, Wu Y, Quick M, Coleman JA, MacDonald WA, Elbakri R, Olsen AL, Rocha EM, Miller GW, De Miranda BR, Palladino MJ, McCabe BD, Fish KN, Seney ML, Rayport S, Mingote S, Deisseroth K, Hnasko TS, Awatramani R, Watson AM, Waddell S, Cheetham CEJ, Logan RW, Freyberg Z.

bioRxiv [Preprint]. 2025 Jul 10:2023.10.02.560584. doi: 10.1101/2023.10.02.560584.

Gut microbiota-derived short chain fatty acids act as mediators of the gut-brain axis targeting age-related neurodegenerative disorders: a narrative review

Guo B, Zhang J, Zhang W, Chen F, Liu B.

Crit Rev Food Sci Nutr. 2025;65(2):265-286. doi: 10.1080/10408398.2023.2272769. Epub 2023 Oct 27.

A framework for integrating artificial intelligence for clinical care with continuous therapeutic monitoring

Chen E, Prakash S, Janapa Reddi V, Kim D, Rajpurkar P.

Nat Biomed Eng. 2025 Apr;9(4):445-454. doi: 10.1038/s41551-023-01115-0. Epub 2023 Nov 6.

Plasma cytokines profile in patients with Alzheimer's and Parkinson's Disease: a comparative study in terms of inflammation

Shateri S, Khatami SH, Haghbin Toutounchi A, Rajaei S, Mahdavi M, Mahmoodi Baram S, Shahidi GA, Habibi AH, Aghamollaii V, Ghlichnia B, Safakish L, Doagoo A, Salmani F, Tafakhori A, Keramatinia A, Shahmohammadi MR, Karima S.

Int J Neurosci. 2025 Feb;135(2):158-167. doi: 10.1080/00207454.2023.2292951. Epub 2023 Dec 15.

SBM vs VBM for highlighting similarities and differences between chronotype and Parkinson's MRI scans: a preliminary analysis

Vacca S, Suri JS, Saba L.

Int J Neurosci. 2025 Feb;135(2):203-212. doi: 10.1080/00207454.2023.2292958. Epub 2023 Dec 12.

Comparison of performance on the oral versus written trail making test in patients with movement disorders

Fox-Fuller JT, Vickers KL, Saurman JL, Wechsler R, Goldstein FC.

Appl Neuropsychol Adult. 2025 Sep-Oct;32(5):1469-1475. doi: 10.1080/23279095.2023.2288230. Epub 2023 Dec 8.

Safinamide for pain management in patients with Parkinson's disease

Abilashimova D, Aubakirova M, Abdildin Y, Viderman D.

Rev Neurol (Paris). 2025 Jan-Feb;181(1-2):11-20. doi: 10.1016/j.neurol.2023.10.013. Epub 2023 Dec 15.

The visual stimulation in disorders of consciousness

Ren S, Zhu J, Xie X, Liu X, Jiang H, Ying C, Hu J, Di H, Hu N.

Appl Neuropsychol Adult. 2025 Nov-Dec;32(6):1786-1793. doi: 10.1080/23279095.2023.2292244. Epub 2023 Dec 17.

Alzheimer, Parkinson, dementia, and phytochemicals: insight review

Can B, Sanlier N.

Crit Rev Food Sci Nutr. 2025;65(9):1706-1728. doi: 10.1080/10408398.2023.2299340. Epub 2024 Jan 8.

Updated Intrinsic Role of Phytochemicals against Glyphosate-induced Neurotoxicity: Systematic Review

Fan R, Zheng Y, Naga LDY, Beeraka NM, Ramachandrappa HVP, Suhail SM, Manjula SN, Bannimath N, Sinelniknov MY, Liu J.

Curr Med Chem. 2025;32(16):3243-3257. doi: 10.2174/0109298673257171231115114543.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias